Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 17, Issue 1, 1998, Pages 6-13

  Hofer, M ^a   Joller Jemelka, H I ^b   Grob, P J ^b   Luthy R ^a   Opravil, M ^a  

^a Division of Infectious Diseases   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS DNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; COHORT STUDIES; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 0031919509     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01584356     Document Type: Article

References (46)

1. Hoofnagle JH, Shafritz DA, Popper H: Chronic type B hepatitis and the "healthy" HBsAg carrier state. Hepatology 1987, 7: 758-763.
2. Hyams KC: Risks of chronicity following acute hepatitis B virus infection: a review. Clinical Infectious Diseases 1995, 20: 992-1000.
3. Maruyama T, McLachlan A, Iino S, Koike K, Kurokawa K, Milich DR: The serology of chronic hepatitis B infection revisited. Journal of Clinical Investigation 1993, 1: 2586-2595.
4. Szmuness W, Prince AM, Grady GF, Mann MK, Levine RW, Friedman EA, Jacobs MJ, Josephson A, Ribot S, Shapiro FL, Stenzel KH, Suki WN, Vyas G: Hepatitis B infection: a point-prevalence study in 15 US hemodialysis centers. Journal of the American Medical Association 1974, 227: 901-906.
5. Szmuness W, Pick R, Prince AM: The serum hepatitis virus specific antigen (SH): a preliminary report of epidemiologic studies in an institution for the mentally retarded. American Journal of Epidemiology 1970, 92: 51-61.
6. Krogsgaard K, Lindhardt BO, Nielson JO, Andersson P, Kryger P, Aldershvile J, Gerstoft J, Pedersen C: The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers. Hepatology 1987, 7: 37-41.
7. Bodswoth NJ, Cooper DA, Donovan B: The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state. Journal of Infectious Diseases 1991, 163: 1138-1140.
8. Luo KX, Zhou R, He C, Liang ZS, Jiang SB: Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen. Journal of Medical Virology 1991, 35: 55-59.
9. Scheitlin T, Grob PJ: Hepatitis and HIV infection in users of illegal drugs. Schweizerische Medizinische Wochenschrift 1992, 122: 1432-1445.
10. Shin LN, Sheu JC, Wang JT, Huang GT, Chen JS, Sung JL, Wang TH, Chen DS: Detection of hepatitis B viral DNA by polymerase chain reaction in patients with hepatitis B surface antigen. Journal of Medical Virology 1990, 30: 159-162.
11. Gerken G, Paterlini P, Manns M, Housset C, Terre S, Dienes HP, Hess G, Gerlich WH, Berthelot P, Meyer zum Büschenfelde KH, Brechot C: Assay of hepatitis B virus DNA by polymerase chain reaction and its relationship to pre-S and S-encoded viral surface antigens. Hepatology 1991, 13: 158-166.
12. Baker BL, Di-Bisceglie AM, Kaneko S, Miller R, Feinstone SM, Waggoner JG, Hoofnagle JH: Determination of hepatitis B virus DNA in serum using the polymerase chain reaction: clinical significance and correlation with serological and biochemical markers. Hepatology 1991, 13: 632-636.
13. Chemin I, Baginski I, Petit MA, Zoulim F, Pichoud C, Capel F, Hantz O, Trepo C: Correlation between HBV DNA detection by polymerase chain reaction and pre-S1 antigenemia in symptomatic and asymptomatic hepatitis B virus infection. Journal of Medical Virology 1991, 33: 51-57.
14. Pao CC, Yao DS, Lin CY, Kao SM, Tsao KC, Sun CF, Liaw YF: Serum hepatitis B virus DNA in hepatitis B virus seropositive and seronegative patients with normal liver function. American Journal of Clinical Pathology 1991, 95: 591-596.
15. Liang TJ, Bodenheimer HC Jr, Yankee R, Brown NV, Chang K, Huang J, Wands JR: Presence of hepatitis B and C viral genomes in US blood donors as detected by polymerase chain reaction amplification. Journal of Medical Virology 1994, 42: 151-157.
16. Wang JT, Wang TH, Sheu JC, Shih LN, Lin JT, Chen DS: Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. Journal of Infectious Diseases 1991, 163: 397-399.
17. Jilg W, Sieger E, Zachoval R, Schätzl H: Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. Journal of Hepatology 1995, 23: 14-20.
18. Gross A, Jolle Jemelka HI, Wicki AN, Grob PJ: Hepatitis serological finding "anti-HBc alone", circulating viral DNA and interpretation of findings. Schweizerische Medizinische Wochenschrift 1993, 123: 1193-1202.
19. Ledergerber B, von Overbeck J, Egger M, Lüthy R, and the Swiss HIV Cohort Study (SHCS): The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristics. Sozial- und Präventivmedizin 1994, 39: 387-394.
20. Joller-Jemelka HI, Wicki AN, Grob PJ: Detection of HBs antigen in "anti-HBc alone" positive sera. Journal of Hepatology 1994, 21: 269-272.
21. Kaneko S, Feinstone SM, Miller R: Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the polymerase chain reaction technique. Journal of Clinical Microbiology 1989, 27: 1930-1933.
22. Kashala O, Mubikayi L, Kayembe K, Mukeba P, Essex M: Hepatitis B virus activation among central Africans infected with human immunodeficiency virus (HIV) type 1: pre-s2 antigen is predominantly expressed in HIV infection. Journal of Infectious Diseases 1994, 169: 628-632.
23. Ranki M, Schätzl HM, Zachoval R, Uusi-Oukari M, Lehtovaara P: Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and recurrent infection. Hepatology 1995, 21: 1492-1499.
24. Chung HT, Lai CL, Lok AS: Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis. Hepatology 1995, 22: 25-29.
25. Paterlini P, Gerken G, Nakajima E, Terre S, D'Errico A, Grigioni W, Nalpas B, Franco D, Wands J, Kew M, Pisi E, Tiollais P, Brechot C: Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. New England Journal of Medicine 1990, 323: 80-85.
26. Liang TJ, Baruch Y, Ben-Porath E, Enat R, Bassan L, Brown NV, Rimon N, Blum HE, Wands JR: Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology 1991, 13: 1044-1051.
27. Bréchot C, Degos F, Lugassy C, Thiers V, Zafrani S, Franco D, Bismuth H, Trepo C, Benhamou JP, Wands J, Isselbacher K, Tiollais P, Berthelot P: Hepatitis B virus DNA in patients with chronic liver disease and negative test for hepatitis B surface antigen. New England Journal of Medicine 1985, 312: 270-276.
28. Lok ASF, Ma OCK: Hepatitis B virus replication in Chinese patients with hepatocellular carcinoma. Hepatology 1990, 12: 582-588.
29. Gilson RJC, Hawkins AE, Beecham MR, Ross E, Waite J, Briggs M, McNally T, Kelly GE, Tedder RS, Weller IVD: Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS 1997, 11: 597-606.
30. Hoofnagle JH, Seeff IB, Buskell-Bales Z, Zimmerman HJ: Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. New England Journal of Medicine 1978, 298: 1379-1383.
31. Katchaki JN, Brouwer R, Siem TH: Anti-HBc and blood infectivity. New England Journal of Medicine 1978, 298: 1421-1422.
32. Sugg U, Erhardt S, Schneider W: Chronic low level hepatitis B virus carrier with probable infectivity. Lancet 1982, i: 446-447.
33. Hopkins R, Kane E, Robertson AE, Haase G: Hepatitis B virus transmitted by HBsAg-negative blood containing anti-HBc. Medical Laboratory Sciences 1982, 39: 61-62.
34. Larsen J, Hetland G, Skaug K: Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier. Transfusion 1990, 30: 431-432.
35. Luo KX, Liang ZS, Yang SC, Zhou R, Meng QH, Zhu YW: Etiological investigation of acute post-transfusion non-A, non-B hepatitis in China. Journal of Medical Virology 1993, 39: 219-223.
36. Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, Roberts JP, Tomlanovich SJ, Vincenti F, Roberts JP, Tomlanovich SJ, Vincenti F, Stock P: The risk of transmission of hepatitis B from HBsAg(-), HBcAB(+), HBIgM(-) organ donors. Transplantation 1995, 59: 230-234.
37. Descos B, Scotto J, Fayol V, Huet JY, Pichoud C, Hermier M, Ville G, Charvet F, Dargent D, Thoulon JM, Trepo C: Anti-HBc screening for the prevention of perinatal transmission of hepatitis B virus in France. Infection 1987, 15: 434-439.
38. Dragosics B, Ferenci P, Hitchman E, Denk H: Long-term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Australia: a clinical and histologic evaluation of 242 cases. Hepatology 1987, 7: 302-306.
39. Liaw YF, Sheen IS, Chen TJ, Chu CM, Pao CC: Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study. Hepatology 1991, 13: 627-631.
40. Sampliner RE, Hamilton FA, Iseri OA, Tabor E, Boitnott J: The liver histology and frequency of clearance of the hepatitis B surface antigen (HBsAg) in chronic carriers. American Journal of the Medical Sciences 1979, 277: 17-22.
41. Lindsay KL, Redeker AG, Aschcavai M: Delayed HBsAg clearance in chronic hepatitis B viral infection. Hepatology 1981, 1: 586-589.
42. Quan CM, Krajden M, Grigoriew GA, Salit IE: Hepatitis C virus infection in patients infected with the human immunodeficiency virus. Clinical Infectious Diseases 1993, 17: 117-119.
43. Cribier B, Rey D, Schmitt C, Lang JM, Kirn A, Stoll-Keller F: High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. AIDS 1995, 9: 1131-1136.
44. Mendel I, Clotteau L, Lambert S, Buffet-Janvresse C: Hepatitis C virus infection in an HIV-positive population in Normandy: antibodies, HCV RNA and genotype prevalence. Journal of Medical Virology 1995, 47: 231-236.
45. Sanchez-Quijano A, Andreu J, Gavilan F, Luque F, Abad MA, Soto B, Muñoz J, Aznar JM, Leal M, Lissen E: Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired hepatitis C. European Journal of Clinical Microbiology & Infectious Diseases 1995, 14: 949-953.
46. Dorrucci M, Pezzotti P, Phillips AN, Lepri AC, Rezza G for the Italian Seroconversion Study: Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. Journal of Infectious Diseases 1995, 172: 1503-1508.